The International Society for Evidence-Based Neonatology (EBNEO)
Mission
EBNEO is an international non-profit promoting evidence-based neonatal practice
Staying up-to-date with literature is hard.
We support your evidence-based practice through literature curation and dissemination.
"Technology is best when it brings people together."
We use modern media to connect the global neonatal community.
Alerts
EBNEO Commentary: Patent Ductus Arteriosus (PDA)-To treat early or not with ibuprofen?
EBNEO Commentary: Patent Ductus Arteriosus (PDA)-To treat early or not with ibuprofen? EBNEO Commentary on EARLY PDA SCREENING & TREATMENT – should we do it? Commentary on recent NEJM RCT! Learn more here!
EBNEO Commentary: Management and outcomes of periviable neonates born at 22 weeks of gestation: a single-center experience in Japan
EBNEO Commentary: Management and outcomes of periviable neonates born at 22 weeks of gestation: a single-center experience in Japan EBNEO Commentary on a single-center report of the management and outcomes of those born at 22 weeks gestational age. Can we improve through sharing information and experience?
EBNEO COMMENTARY: REDUCING EXTUBATION FAILURE IN EXTREME PRETERM INFANTS – HIGHER VS STANDARD nCPAP
EBNEO COMMENTARY: REDUCING EXTUBATION FAILURE IN EXTREME PRETERM INFANTS – HIGHER VS STANDARD nCPAP EBNEO Commentary addresses recent RCT asking whether the CPAP level you choose can impact risk of extubation failure! Read more here!
Reviews
EBNEO Commentary: Patent Ductus Arteriosus (PDA)-To treat early or not with ibuprofen?
EBNEO Commentary: Patent Ductus Arteriosus (PDA)-To treat early or not with ibuprofen? EBNEO Commentary on EARLY PDA SCREENING & TREATMENT – should we do it? Commentary on recent NEJM RCT! Learn more here!
EBNEO Commentary: Management and outcomes of periviable neonates born at 22 weeks of gestation: a single-center experience in Japan
EBNEO Commentary: Management and outcomes of periviable neonates born at 22 weeks of gestation: a single-center experience in Japan EBNEO Commentary on a single-center report of the management and outcomes of those born at 22 weeks gestational age. Can we improve through sharing information and experience?
EBNEO COMMENTARY: REDUCING EXTUBATION FAILURE IN EXTREME PRETERM INFANTS – HIGHER VS STANDARD nCPAP
EBNEO COMMENTARY: REDUCING EXTUBATION FAILURE IN EXTREME PRETERM INFANTS – HIGHER VS STANDARD nCPAP EBNEO Commentary addresses recent RCT asking whether the CPAP level you choose can impact risk of extubation failure! Read more here!
Contact us
International Society for Evidence-Based Neonatology
